Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease
characterized by progressive pulmonary artery pressure elevation, increased pulmonary …

Pulmonary hypertension (PH) refers to a clinical and pathophysiological syndrome in which
pulmonary vascular resistance and pulmonary arterial pressure are increased due to …

The brain is the main oxygen-consuming organ and is vulnerable to ischemic shock or
insufficient blood perfusion. Brain hypoxia has a persistent and detrimental effect on resident …

Batch effects in omics data are notoriously common technical variations unrelated to study
objectives, and may result in misleading outcomes if uncorrected, or hinder biomedical …

Objective: Regulatory T cells (Tregs) are critical immune modulators to maintain immune
homeostasis and limit pulmonary hypertension (PH). This study was aimed to identify Treg …

Pulmonary hypertension due to left heart disease (PH‐LHD) is regarded as the most
prevalent form of pulmonary hypertension (PH). Indeed, PH is an independent risk factor …

Aim Chronic hypoxia is a common cause of pulmonary hypertension (PH). We test the
hypothesis that microRNA‐210 (miR‐210) mediates hypoxia‐induced PH by targeting …

Pulmonary arterial hypertension, or PAH, is a condition that is characterized by pulmonary
artery pressures above 20 mmHg (at rest). In the treatment of PAH, the pulmonary vascular …

Prolactin (PRL) is a polypeptide hormone that is mainly synthesized and secreted by the
lactotroph cells of the pituitary. There are two main isoforms of PRL: 23‐kDa PRL (named full …

Pulmonary artery endothelial cells (PAECs) are a major contributor to hypoxic pulmonary
hypertension (PH) due to the possible roles of reactive oxygen species (ROS). However, the …